TY  - JOUR

T1  - The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States

JO  - Clinical Journal of the American Society of Nephrology

PY  - 2022/02/03

AU  - Mandrik O

AU  - Fotheringham J

AU  - Ren S

AU  - Tice JA

AU  - Chapman RH

AU  - Stevenson MD

AU  - Pearson SD

AU  - Herron-Smith S

AU  - Agboola F

AU  - Thokala P

ED  - 

DO  - DOI: 10.2215/cjn.13030921

PB  - American Society of Nephrology (ASN)

VL  - 17

IS  - 3

SP  - 385

EP  - 394

Y2  - 2024/10/18

ER  -